Skip to main content
. 2013 Dec 15;7(1):280–287.

Table 1.

Expression of ASAP1 expression in EOC patients according to clinicopathologic characteristics

Characteristics NO. ASAP1 p

Positive N (%) Negative N (%)
Age (y) 0.750
    ≤50 39 21 (53.8) 18 (46.2)
    >50 56 32 (57.1) 24 (42.9)
FIGO Stage 0.346
    I-II 39 24 (37.8) 15 (62.2)
    III-IV 56 29 (67.2) 27 (32.8)
Differentiation 0.191
    Grade 1/2 61 31 (50.8) 30 (49.2)
    Grade 3 34 22 (64.7) 12 (35.3)
Pelvic Metastasis 0.015
    - 78 39 (50.0) 39 (50.0)
    + 17 14 (82.4) 3 (17.6)